These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The human clinical phenotypes of altered CHRNA7 copy number. Gillentine MA; Schaaf CP Biochem Pharmacol; 2015 Oct; 97(4):352-362. PubMed ID: 26095975 [TBL] [Abstract][Full Text] [Related]
6. The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function. Sinkus ML; Graw S; Freedman R; Ross RG; Lester HA; Leonard S Neuropharmacology; 2015 Sep; 96(Pt B):274-88. PubMed ID: 25701707 [TBL] [Abstract][Full Text] [Related]
7. Screening for Copy Number Variations of the 15q13.3 Hotspot in Özaltun MF; Geyik S; Yılmaz ŞG Curr Issues Mol Biol; 2021 Sep; 43(2):1090-1113. PubMed ID: 34563047 [TBL] [Abstract][Full Text] [Related]
8. The holistic approach to the Yasin S; Görücü Yılmaz Ş; Geyik S; Oğuzkan Balcı S Mol Pain; 2023; 19():17448069231152104. PubMed ID: 36604774 [TBL] [Abstract][Full Text] [Related]
9. Copy number variations in healthy subjects. Case study: iPSC line CSSi005-A (3544) production from an individual with variation in 15q13.3 chromosome duplicating gene CHRNA7. Turco EM; Vinci E; Altieri F; Ferrari D; Torres B; Goldoni M; Lamorte G; Tata AM; Mazzoccoli G; Postorivo D; Della Monica M; Bernardini L; Vescovi AL; Rosati J Stem Cell Res; 2018 Oct; 32():73-77. PubMed ID: 30218896 [TBL] [Abstract][Full Text] [Related]
10. CHRNA7 copy number gains are enriched in adolescents with major depressive and anxiety disorders. Gillentine MA; Lozoya R; Yin J; Grochowski CM; White JJ; Schaaf CP; Calarge CA J Affect Disord; 2018 Oct; 239():247-252. PubMed ID: 30029151 [TBL] [Abstract][Full Text] [Related]
11. 15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain. Yasui DH; Scoles HA; Horike S; Meguro-Horike M; Dunaway KW; Schroeder DI; Lasalle JM Hum Mol Genet; 2011 Nov; 20(22):4311-23. PubMed ID: 21840925 [TBL] [Abstract][Full Text] [Related]
12. 15q13.3 duplication in two patients with childhood-onset schizophrenia. Zhou D; Gochman P; Broadnax DD; Rapoport JL; Ahn K Am J Med Genet B Neuropsychiatr Genet; 2016 Sep; 171(6):777-83. PubMed ID: 26968334 [TBL] [Abstract][Full Text] [Related]
13. Chrna7 deficient mice manifest no consistent neuropsychiatric and behavioral phenotypes. Yin J; Chen W; Yang H; Xue M; Schaaf CP Sci Rep; 2017 Jan; 7():39941. PubMed ID: 28045139 [TBL] [Abstract][Full Text] [Related]
14. Chromosome 15q13.3 microduplications are associated with treatment refractory major depressive disorder. McClain L; Segreti AM; Nau S; Shaw P; Finegold DN; Pan LA; Peters DG Genes Brain Behav; 2020 Jun; 19(5):e12628. PubMed ID: 31828948 [TBL] [Abstract][Full Text] [Related]
15. The 15q13.3 deletion syndrome: Deficient α(7)-containing nicotinic acetylcholine receptor-mediated neurotransmission in the pathogenesis of neurodevelopmental disorders. Deutsch SI; Burket JA; Benson AD; Urbano MR Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():109-17. PubMed ID: 26257138 [TBL] [Abstract][Full Text] [Related]
16. CHRNA7 Deletions are Enriched in Risperidone-Treated Children and Adolescents. Gillentine MA; White JJ; Grochowski CM; Lupski JR; Schaaf CP; Calarge CA J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):908-915. PubMed ID: 28817303 [TBL] [Abstract][Full Text] [Related]
17. A Link between Genetic Disorders and Cellular Impairment, Using Human Induced Pluripotent Stem Cells to Reveal the Functional Consequences of Copy Number Variations in the Central Nervous System-A Close Look at Chromosome 15. Casamassa A; Ferrari D; Gelati M; Carella M; Vescovi AL; Rosati J Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182809 [TBL] [Abstract][Full Text] [Related]
18. An acetylcholine alpha7 positive allosteric modulator rescues a schizophrenia-associated brain endophenotype in the 15q13.3 microdeletion, encompassing CHRNA7. Gass N; Weber-Fahr W; Sartorius A; Becker R; Didriksen M; Stensbøl TB; Bastlund JF; Meyer-Lindenberg A; Schwarz AJ Eur Neuropsychopharmacol; 2016 Jul; 26(7):1150-60. PubMed ID: 27061851 [TBL] [Abstract][Full Text] [Related]
19. Genetic mapping of putative Chrna7 and Luzp2 neuronal transcriptional enhancers due to impact of a transgene-insertion and 6.8 Mb deletion in a mouse model of Prader-Willi and Angelman syndromes. Stefan M; Claiborn KC; Stasiek E; Chai JH; Ohta T; Longnecker R; Greally JM; Nicholls RD BMC Genomics; 2005 Nov; 6():157. PubMed ID: 16280085 [TBL] [Abstract][Full Text] [Related]
20. CHRNA7 triplication associated with cognitive impairment and neuropsychiatric phenotypes in a three-generation pedigree. Soler-Alfonso C; Carvalho CM; Ge J; Roney EK; Bader PI; Kolodziejska KE; Miller RM; Lupski JR; Stankiewicz P; Cheung SW; Bi W; Schaaf CP Eur J Hum Genet; 2014 Sep; 22(9):1071-6. PubMed ID: 24424125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]